Selective angiotensin II receptor antagonism reduces insulin resistance in obese Zucker rats.
D057911:Angiotensin Receptor Antagonists; D000818:Animals; D019540:Area Under Curve; D001692:Biological Transport / Q000187:drug effects; D001713:Biphenyl Compounds / Q000494:pharmacology*; D001786:Blood Glucose / Q000187:drug effects / Q000378:metabolism; D001835:Body Weight / Q000187:drug effects; D003847:Deoxyglucose / Q000493:pharmacokinetics; D004305:Dose-Response Relationship, Drug; D005230:Fatty Acids, Nonesterified / Q000378:metabolism; D005260:Female; D005951:Glucose Tolerance Test; D051275:Glucose Transporter Type 4; D006321:Heart / Q000254:growth & development; D007328:Insulin / Q000097:blood / Q000493:pharmacokinetics / Q000494:pharmacology; D007333:Insulin Resistance; D000077405:Irbesartan; D009004:Monosaccharide Transport Proteins / Q000187:drug effects / Q000378:metabolism; D009124:Muscle Proteins; D018482:Muscle, Skeletal / Q000187:drug effects / Q000378:metabolism; D009765:Obesity / Q000378:metabolism*; D009929:Organ Size / Q000187:drug effects; D051381:Rats; D011924:Rats, Zucker; D013777:Tetrazoles / Q000494:pharmacology*